Skip to content
healthcare.dev

AMPYRA

NDC 10144-427, Dalfampridine, tablet, film coated, extended release, from Merz Pharmaceuticals, LLC.

Product NDC
10144-427
Status
Listed
Labeler
Merz Pharmaceuticals, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022250
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10144-427 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALFAMPRIDINE10 mg/1

Pharmacologic classes

Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]

Package NDCNDC-11Package
10144-427-601014404276060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783

Use it

Look up 10144-427 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10144-427 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10144-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.